|
|
||||||||
From the Department of Neurology (Drs. Jahn and Bufler), Medizinische Hochschule Hannover; and the Department of Neurology (Dr. Franke), Technical University of Munich, Germany.
Address correspondence and reprint requests to Priv. Doz. Dr. J. Bufler, Department of Neurology, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
OBJECTIVE: To clarify the mechanism of block of nicotinic receptor channels by myasthenic antibodies.
BACKGROUND: Nicotinic acetylcholine receptor (nAChR) channel currents are functionally blocked by purified immunoglobulin G (IgG) of patients with myasthenia gravis (MG).
METHODS: The molecular mechanism of block of IgG fractions containing antibodies to nAChR channels was tested with the patch-clamp technique in combination with a system for ultrafast solution exchange. For the experiments, outside-out patches from cultured mouse myotubes that express embryonic-type nAChR channels at their surface were used.
RESULTS: Incubation of outside-out patches with purified IgG from four myasthenic patients blocked nAChR channel currents activated by the application of 1.0 mM ACh reversibly. The peak current amplitude and the time course of block of nAChR channels decreased with increasing concentrations of IgG. The block became at least partly irreversible if incubation time of outside-out patches exceeded 2 minutes. For the block of nAChR channel currents with
-bungarotoxin, a similar mechanism of block was found.
CONCLUSIONS: The reversibility of functional block of nAChR channel currents by myasthenic IgG depended strongly on the incubation time of the receptors with antibodies. Interaction of myasthenic antibodies with nicotinic receptors may proceed in several stages from a low-affinity reversible to a high-affinity irreversible binding.
Key words: Myasthenia gravisBlock mechanismMyasthenic antibodiesImmunoglobulin GPatch-clamp techniqueUltrafast applicationNicotinic acetylcholine receptor
This article has been cited by other articles:
![]() |
A. De Haes, J. H. Proost, J. B. M. Kuks, D. C. van den Tol, and J. M. K. H. Wierda Pharmacokinetic/Pharmacodynamic Modeling of Rocuronium in Myasthenic Patients Is Improved by Taking into Account the Number of Unbound Acetylcholine Receptors Anesth. Analg., September 1, 2002; 95(3): 588 - 596. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |